TP53 and cancer: It is noteworthy in this respect that studies on some anti-cancer agents have shown that RNA damage can lead to cell-cycle arrest and cell death, via a p53-dependent mechanism associated with inhibition of protein synthesis or p53-independent mechanism as yet uncharacterized [103].